-+ 0.00%
-+ 0.00%
-+ 0.00%

China SXT Pharmaceuticals issues warrants in USD 9 million registered direct offering

PUBT·07/23/2026 12:45:22
Listen to the news
China SXT Pharmaceuticals issues warrants in USD 9 million registered direct offering
  • China SXT Pharmaceuticals launched a registered direct offering of 4,500,000 units at USD 2 per unit for about USD 9 million gross.
  • Each unit includes one Class A ordinary share, one common warrant exercisable immediately at USD 3.2, expiring one year from issuance.
  • Closing expected around July 24, 2025, subject to customary conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607230845PRIMZONEFULLFEED9767069) on July 23, 2026, and is solely responsible for the information contained therein.